Key result
Conservative management of distally embolised drug-coated balloon proves safe with no 12-month ischaemic events.
Why the study?
Device dislodgment during PCI is a rare but potentially life-threatening complication with limited guidance on management strategies for distal embolisation of drug-coated balloons.
Case Report (n=1)
No
Conservative management of an inadvertently distally embolised drug-coated balloon may be a safe and feasible strategy in carefully selected patients with preserved coronary flow and no angiographic complications.
Conservative management may be viable with preserved TIMI 3 flow; hypothesis-generating for device embolisation and requires prospective validation.
Background: Balloon angioplasty can lead to multiple complications, such as myocardial perforation and dissection of coronary arteries. Device dislodgment during percutaneous coronary intervention (PCI) is a rare but potentially life-threatening complication. Case description: We report on a 67-year-old woman presenting with acute coronary syndrome due to in-stent restenosis of the left circumflex artery, treated with a drug-coated balloon (DCB) following lesion preparation. During DCB retrieval resistance was encountered, and angiography revealed separation of the balloon from its shaft with distal embolisation. Despite this, thrombolysis in myocardial infarction (TIMI) flow grade 3 was preserved. After multidisciplinary discussion, conservative management was chosen due to the distal location of the embolised device and risks associated with retrieval. Final angiography showed no procedural complication, and at 12-month follow-up, the patient remained asymptomatic without ischaemic or device-related events. Conclusion: This example shows that in certain patients with intact coronary flow and no procedural complications, conservative therapy of distal DCB embolisation might be a safe and feasible strategy. LEARNING POINTS: This case highlights that, in selected patients, leaving an embolised device in situ may be a safe and feasible strategy when distal flow is preserved and procedure risks outweigh benefits of retrieval.
No takes yet. Share an insight, caveat, or question.
Luai Alhazmi (2026) conducted a case report in Acute coronary syndrome with in-stent restenosis and distal device embolisation (n=1). Conservative management (leaving device in situ) was evaluated on Clinical outcome at follow-up. Conservative management of an unintended distal drug-coated balloon embolisation was safe and feasible, with the patient remaining asymptomatic without ischaemic events at 12 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: